Depot medroxyprogesterone acetate inhibits the secretion of pituitary gonadotropins, resulting in anovulation and decreased production of estrogen
Depo-Provera and BMD in Adolescents
Osteocyte apoptosis may contribute to age-related osteoporosis either directly or through the elaboration of systemic peptides
Bone Density Bone Density Loss and Depo: Who's at Risk? By Rachel Walden — December 23, 2009 The current issue of the journal Obstetrics & Gynecology
Summarize the potential adverse effects of medroxyprogesterone in its different forms
whether Depo-Provera increases the risk of osteoporosis (weak bones) and fractures in later life (after the menopause)